Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 24603218)

1.

Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease.

Williams PT, Zhao XQ, Marcovina SM, Otvos JD, Brown BG, Krauss RM.

Atherosclerosis. 2014 Apr;233(2):713-20. doi: 10.1016/j.atherosclerosis.2014.01.034. Epub 2014 Jan 30.

2.
3.
4.

Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.

Tribble DL, Farnier M, Macdonell G, Perevozskaya I, Davies MJ, Gumbiner B, Musliner TA.

Metabolism. 2008 Jun;57(6):796-801. doi: 10.1016/j.metabol.2008.01.026.

PMID:
18502262
5.
6.

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

Syvänne M, Nieminen MS, Frick MH, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Ehnholm C, Taskinen MR.

Circulation. 1998 Nov 10;98(19):1993-9.

8.

Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA.

Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1046-53.

11.
12.

Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.

Chung CP, Oeser A, Raggi P, Sokka T, Pincus T, Solus JF, Linton MF, Fazio S, Stein CM.

J Rheumatol. 2010 Aug 1;37(8):1633-8. doi: 10.3899/jrheum.090639. Epub 2010 Jun 1.

13.

Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models.

Petersen M, Dyrby M, Toubro S, Engelsen SB, Nørgaard L, Pedersen HT, Dyerberg J.

Clin Chem. 2005 Aug;51(8):1457-61. Epub 2005 Jun 16.

14.
15.

Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women.

Maki KC, Dicklin MR, Davidson MH, Mize PD, Kulkarni KR.

Vasc Health Risk Manag. 2012;8:31-8. doi: 10.2147/VHRM.S27963. Epub 2012 Jan 16.

16.

Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.

Hodis HN, Mack WJ, Dunn M, Liu C, Liu C, Selzer RH, Krauss RM.

Circulation. 1997 Apr 15;95(8):2022-6.

17.

Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ; Pittsburgh Epidemiology of Diabetes Complications Study.

Diabetologia. 2003 May;46(5):674-82. Epub 2003 May 13.

PMID:
12743701
18.

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH.

Circulation. 1994 Jul;90(1):42-9.

PMID:
8026027
20.

Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

Magkos F, Mohammed BS, Mittendorfer B.

Int J Obes (Lond). 2008 Nov;32(11):1655-64. doi: 10.1038/ijo.2008.164. Epub 2008 Sep 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk